Impact BioMedical Announces 1-For-12.62 Reverse Stock Split, Reducing Shares Outstanding From ~107.8M To ~8.54M, Effective Sept. 23
Impact BioMedical Inc. (the "Company") today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued and outstanding common stock, par value
A company is combining its shares so fewer, bigger shares exist instead. This usually means the stock price was very low, and the company wants to fix that on paper.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.